These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 4810052
1. The topographical differences in the active site region of alpha-chymotrypsin, subtilisin Novo, and subtilisin Carlsberg. Mapping the aromatic binding site by inhibitors (virtual substrates). Bosshard HR, Berger A. Biochemistry; 1974 Jan 15; 13(2):266-77. PubMed ID: 4810052 [No Abstract] [Full Text] [Related]
2. Specificities of alpha-chymotrypsin and subtilisin Carlsberg. The alpha-acylamido effect in beta-phenylpropionates and their rigid analogs. Matta MS, Staley DD. J Biol Chem; 1974 Feb 10; 249(3):732-7. PubMed ID: 4811900 [No Abstract] [Full Text] [Related]
3. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors. Brömme D, Fittkau S. Biomed Biochim Acta; 1985 Feb 10; 44(7-8):1089-94. PubMed ID: 3910035 [Abstract] [Full Text] [Related]
4. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site. Karasaki Y, Ohno M. J Biochem; 1978 Sep 10; 84(3):531-8. PubMed ID: 102640 [Abstract] [Full Text] [Related]
6. Interactions of alpha-chymotrypsin and Carlsberg subtilisin with methyl N alpha-acetyl-2-(alkylthio)-L-tryptophanoates. Yoshizumi K, Kamiyama K, Shieh TC, Tanaka S, Ohno M. J Biochem; 1986 Nov 10; 100(5):1201-6. PubMed ID: 3546277 [Abstract] [Full Text] [Related]
7. The aromatic substrate binding site in subtilisin BPN' and its resemblance to chymotrypsin. Kraut J, Robertus JD, Birktoft JJ, Alden RA, Wilcox PE, Powers JC. Cold Spring Harb Symp Quant Biol; 1972 Nov 10; 36():117-23. PubMed ID: 4508128 [No Abstract] [Full Text] [Related]
12. Substrate binding site in bovine chymotrypsin A-gamma. A crystallographic study using peptide chloromethyl ketones as site-specific inhibitors. Segal DM, Powers JC, Cohen GH, Davies DR, Wilcox PE. Biochemistry; 1971 Sep 28; 10(20):3728-38. PubMed ID: 5107010 [No Abstract] [Full Text] [Related]
13. Reaction of azapeptides with chymotrypsin-like enzymes. New inhibitors and active site titrants for chymotrypsin A alpha, subtilisin BPN', subtilisin Carlsberg, and human leukocyte cathepsin G. Gupton BF, Carroll DL, Tuhy PM, Kam CM, Powers JC. J Biol Chem; 1984 Apr 10; 259(7):4279-87. PubMed ID: 6368557 [Abstract] [Full Text] [Related]
14. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo. McPhalen CA, James MN. Biochemistry; 1988 Aug 23; 27(17):6582-98. PubMed ID: 3064813 [Abstract] [Full Text] [Related]
15. Probing the specificity of the S1 binding site of subtilisin Carlsberg with boronic acids. Seufer-Wasserthal P, Martichonok V, Keller TH, Chin B, Martin R, Jones JB. Bioorg Med Chem; 1994 Jan 23; 2(1):35-48. PubMed ID: 7922119 [No Abstract] [Full Text] [Related]
16. Preparation and kinetic properties of a new form of chymotrypsin which is active at alkaline pH: 1 -chymotrypsin. Valenzuela P, Bender ML. J Biol Chem; 1973 Jul 25; 248(14):4909-14. PubMed ID: 4736884 [No Abstract] [Full Text] [Related]